Synthetic Biologics, Inc. (SYN) stock went up by 101.04% and analysts have given it a mean rating of 2.5 as a Hold.
None of the analysts recommended it for selling, and it is expected that EPS will be -$0.13 in this quarter.
SYN has been trading in the green zone for the past five days. In these 5 days, their stock price went up to $0.96, and it showed a jump of 101.04%.
The current value of the stock will increase in the near future as well, the analysts believe. The overall stock market is showing a bullish trend as the markets are slowly opening across the country.
The lowest that SYN stock can go in the future is still higher than its current price at $1.25, and the highest will be $1.5. This increase from the previous pricing is well over 90%, and this shows the positive growth of the company.
For the future, these numbers may vary, but the company is certain for its earnings to grow.
Institutional shareholding is closely analyzed by the analyst and 28 institutes hold their shares in the company. The largest among them all is Renaissance Technologies, LLC which has the highest shareholding with 859,740 shares in the company.
The number of shares owned, depict the control over the company that the institutions can show and Renaissance Technologies, LLC has 4.3% outstanding shares.
Next to Renaissance Technologies, LLC, Vanguard Group, Inc. only holds 0.62% in the company, with 123,390 outstanding shares.
Stock markets crashed in the last year and all the companies suffered equally due to recession. All this happened because of the coronavirus, as the lockdowns were implemented all across America.
NYSE did not manage to recover from the consequences soon enough. Despite the disturbing events in Washington DC, the investors still sought their interests in NYSE-listed companies and SYN is one of them.
Many companies are set to welcome their employees back, which will lead to a lower unemployment rate. This also means that the companies will be sought for sound investments, and SYN will also see potential growth.